| 注册
首页|期刊导航|中国药业|不同剂量右美托咪定预防腹腔镜患者全身麻醉苏醒期躁动及寒战临床评价

不同剂量右美托咪定预防腹腔镜患者全身麻醉苏醒期躁动及寒战临床评价

吴静 杨帆

中国药业2016,Vol.25Issue(9):25-26,27,3.
中国药业2016,Vol.25Issue(9):25-26,27,3.

不同剂量右美托咪定预防腹腔镜患者全身麻醉苏醒期躁动及寒战临床评价

Different Doses of Dexmedetomidine for Preventing Agitation and Shivering of Patients during Recovery Period of General Anesthesia in Gynecological Laparoscopy

吴静 1杨帆2

作者信息

  • 1. 湖北中医药大学黄家湖医院,湖北 武汉 430070
  • 2. 湖北省武汉市汉口医院,湖北 武汉 430312
  • 折叠

摘要

Abstract

Objective To analyze clinical efficacy of different doses of dexmedetomidine on shivering and agitation of laparoscopic patients with given anesthesia. Methods 60 cases of laparoscopic patients from March 2015 to February 2016 were divided into into group A, B, C, D according to random number table method, 15 cases in each group. Before induction of anesthesia, groups A, B, C were given dexmedetomidine infusion of 0. 5 μg/kg, 0. 75 μg/kg, 1. 0 μg/kg, group D received isovolumetric saline infusion. The occurrence rates of agitation and shivering were compared between the 4 groups. Results The incidence rates of agitation after general anesthesia in groups A, B, C were 26. 67%, 6. 67%, 20. 00%, which were all significantly lower than 53. 33% in group D, and group B ( 6. 67%) was significantly lower than group A ( 26. 67%) ( P < 0. 05 ) . The incidence rates of shivering after general anesthesia in groups A, B, C were 40. 00%, 73. 33%, 46. 67%, which were all significantly higher than 26. 67% in group D, and group B had the most significant preventive efficacy on shivering with statistically significant difference ( P < 0. 05 ) . Conclusion Dexmedetomidine has good good clinical efficacy on preventing agitation and shivering in laparoscopic patients with general anesthesia, and the dose of 0. 75 μg/kg of dexmedetomidine has the best preventive effect with good recovery.

关键词

右美托咪定/腹腔镜/全身麻醉苏醒期/躁动/寒战

Key words

dexmedetomidine/laparoscopy/general anesthesia recovery period/agitation/shivering

分类

医药卫生

引用本文复制引用

吴静,杨帆..不同剂量右美托咪定预防腹腔镜患者全身麻醉苏醒期躁动及寒战临床评价[J].中国药业,2016,25(9):25-26,27,3.

中国药业

OACSTPCD

1006-4931

访问量0
|
下载量0
段落导航相关论文